Dr. David Geffen, O.D

NPI: 1164503678
Total Payments
$281,464
2024 Payments
$11,631
Companies
40
Transactions
752
Medicare Patients
1,523
Medicare Billing
$136,256

Payment Breakdown by Category

Consulting$106,637 (37.9%)
Other$102,597 (36.5%)
Travel$39,783 (14.1%)
Food & Beverage$27,426 (9.7%)
Research$5,000 (1.8%)
Education$20.15 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $106,637 73 37.9%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $41,885 27 14.9%
Travel and Lodging $39,783 170 14.1%
Food and Beverage $27,426 437 9.7%
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $25,325 16 9.0%
Compensation for serving as faculty or as a speaker for a medical education program $22,175 16 7.9%
Honoraria $13,000 8 4.6%
Unspecified $5,000 2 1.8%
Entertainment $212.24 2 0.1%
Education $20.15 1 0.0%

Payments by Type

General
$276,464
750 transactions
Research
$5,000
2 transactions

Top Paying Companies

Company Total Records Latest Year
Bausch & Lomb, a division of Bausch Health US, LLC $67,212 146 $0 (2021)
Alcon Laboratories Inc $48,225 85 $0 (2018)
Bausch & Lomb Americas Inc. $31,823 96 $0 (2024)
Shire North American Group Inc $27,933 80 $0 (2019)
Valeant Pharmaceuticals North America LLC $27,292 76 $0 (2017)
Alcon Vision LLC $26,034 88 $0 (2024)
Johnson & Johnson Surgical Vision, Inc. $18,720 42 $0 (2019)
SUN PHARMACEUTICAL INDUSTRIES INC. $13,025 28 $0 (2024)
TOPCON HEALTHCARE SOLUTIONS, INC. $5,000 2 $0 (2021)
Novartis Pharmaceuticals Corporation $3,975 15 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $11,631 69 Bausch & Lomb Americas Inc. ($7,582)
2023 $11,473 60 Bausch & Lomb Americas Inc. ($9,807)
2022 $14,912 46 Bausch & Lomb Americas Inc. ($14,435)
2021 $24,834 60 Bausch & Lomb, a division of Bausch Health US, LLC ($18,309)
2020 $9,714 37 Bausch & Lomb, a division of Bausch Health US, LLC ($9,385)
2019 $61,280 125 Alcon Vision LLC ($24,165)
2018 $83,293 178 Alcon Laboratories Inc ($37,358)
2017 $64,327 177 Valeant Pharmaceuticals North America LLC ($27,292)

All Payment Transactions

752 individual payment records from CMS Open Payments — Page 1 of 31

Date Company Product Nature Form Amount Type
12/23/2024 BIOTISSUE HOLDINGS INC. Food and Beverage Cash or cash equivalent $192.21 General
12/17/2024 Alcon Vision LLC WaveLight EX500 Excimer Laser (Device) Food and Beverage In-kind items and services $7.39 General
Category: Ophthalmology
12/12/2024 Glaukos Corporation Photrexa (Drug) Food and Beverage Cash or cash equivalent $28.00 General
Category: Corneal Health
12/10/2024 Alcon Vision LLC WaveLight EX500 Excimer Laser (Device) Food and Beverage In-kind items and services $59.97 General
Category: Ophthalmology
12/10/2024 Alcon Vision LLC Clareon (Device) Food and Beverage In-kind items and services $24.58 General
Category: Ophthalmology
12/03/2024 Harrow Eye, LLC VEVYE (Drug) Food and Beverage In-kind items and services $37.31 General
Category: OPTOMETRY
11/13/2024 Glaukos Corporation CE-marked KXLA system (Device) Consulting Fee Cash or cash equivalent $525.00 General
Category: Corneal Health
11/08/2024 Alcon Vision LLC WaveLight EX500 Excimer Laser (Device) Food and Beverage In-kind items and services $62.60 General
Category: Ophthalmology
11/04/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Food and Beverage In-kind items and services $121.36 General
Category: Ophthalmology
10/31/2024 BIOTISSUE HOLDINGS INC. Food and Beverage In-kind items and services $192.21 General
10/30/2024 Tarsus Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $700.00 General
10/21/2024 Glaukos Corporation iDose (Device) Food and Beverage Cash or cash equivalent $25.48 General
Category: Glaucoma
10/16/2024 Bausch & Lomb Americas Inc. INFUSE (Device) Food and Beverage In-kind items and services $107.72 General
Category: Ophthalmology
10/09/2024 Tarsus Pharmaceuticals, Inc. XDEMVY (Drug) Food and Beverage In-kind items and services $22.98 General
Category: DEMODEX BLEPHARITIS
09/30/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA, VYZULTA Food and Beverage In-kind items and services $44.60 General
Category: Ophthalmology
09/20/2024 BIOTISSUE HOLDINGS INC. Travel and Lodging Cash or cash equivalent $124.88 General
09/19/2024 Tarsus Pharmaceuticals, Inc. Food and Beverage In-kind items and services $110.67 General
09/19/2024 SUN PHARMACEUTICAL INDUSTRIES INC. Cequa (Drug), Xelpros, BromSite Food and Beverage In-kind items and services $51.00 General
Category: Ophthalmology
09/09/2024 Harrow Eye, LLC VEVYE (Drug) Food and Beverage In-kind items and services $20.49 General
Category: OPTOMETRY
08/19/2024 BIOTISSUE HOLDINGS INC. Food and Beverage Cash or cash equivalent $125.00 General
08/06/2024 Bausch & Lomb Americas Inc. INFUSE (Device) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $2,000.00 General
Category: Ophthalmology
08/06/2024 Alcon Vision LLC Clareon (Device) Food and Beverage In-kind items and services $96.96 General
Category: Ophthalmology
08/06/2024 Oyster Point Pharma, Inc. TYRVAYA (Drug), Ryzumvi Food and Beverage In-kind items and services $27.44 General
Category: Dry eyes
07/26/2024 Glaukos Corporation GTS100_Glaukos iStent Trabecular Micro-Bypass Stent System (Device) Food and Beverage Cash or cash equivalent $167.27 General
Category: Glaucoma
07/22/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Food and Beverage In-kind items and services $38.99 General
Category: Ophthalmology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 399 409 $71,023 $37,327
2022 4 426 435 $67,262 $38,646
2021 4 438 447 $61,655 $40,011
2020 4 260 265 $31,200 $20,272
Total Patients
1,523
Total Services
1,556
Medicare Billing
$136,256
Procedure Codes
16

All Medicare Procedures & Services

16 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
92014 Established patient complete exam of visual system Office 2023 272 273 $50,025 $26,319 52.6%
92004 New patient complete exam of visual system Office 2023 58 58 $12,370 $5,706 46.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 44 52 $4,884 $3,399 69.6%
92012 Established patient problem focused exam of visual system Office 2023 25 26 $3,744 $1,903 50.8%
92014 Established patient complete exam of visual system Office 2022 290 292 $47,550 $27,259 57.3%
92004 New patient complete exam of visual system Office 2022 56 56 $10,700 $5,897 55.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 48 53 $4,608 $3,179 69.0%
92012 Established patient problem focused exam of visual system Office 2022 32 34 $4,404 $2,311 52.5%
92014 Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits Office 2021 291 291 $41,525 $26,411 63.6%
92004 Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits Office 2021 79 79 $13,405 $9,069 67.7%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 48 56 $4,420 $3,255 73.6%
92012 Eye and medical examination for diagnosis and treatment, established patient Office 2021 20 21 $2,305 $1,276 55.3%
92014 Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits Office 2020 192 193 $23,160 $15,170 65.5%
92004 Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits Office 2020 34 34 $5,100 $3,353 65.7%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 23 27 $2,025 $1,130 55.8%
92012 Eye and medical examination for diagnosis and treatment, established patient Office 2020 11 11 $915.00 $618.62 67.6%

About Dr. David Geffen, O.D

Dr. David Geffen, O.D is a Optometrist healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164503678.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Geffen, O.D has received a total of $281,464 in payments from pharmaceutical and medical device companies, with $11,631 received in 2024. These payments were reported across 752 transactions from 40 companies. The most common payment nature is "Consulting Fee" ($106,637).

As a Medicare-enrolled provider, Geffen has provided services to 1,523 Medicare beneficiaries, totaling 1,556 services with total Medicare billing of $136,256. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.

Practice Information

  • Specialty Optometrist
  • Location San Diego, CA
  • Active Since 10/18/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 152W00000X
  • Entity Type Individual
  • NPI Number 1164503678

Products in Payments

  • DAILIES (Device) $54,545
  • INFUSE (Device) $35,396
  • BIOTRUE (Device) $33,317
  • XIIDRA (Drug) $31,858
  • Tecnis 1-piece IOL (Device) $17,993
  • ULTRA (Device) $14,915
  • ZEN LENS (Device) $10,628
  • ULTRA MULTIFOCAL TORIC (Device) $7,665
  • BIOTRUE ONE DAY (Device) $7,599
  • BromSite (bromfenac ophthalmic solution) 0.075% (Drug) $6,366
  • CEQUA (Drug) $5,998
  • OCT-TRITION (Device) $5,000
  • Wavelight (Device) $4,197
  • AcrySof (Device) $3,463
  • AIR OPTIX (Device) $1,760
  • TearLab Osmolarity System (Device) $1,550
  • iVue (Device) $1,250
  • ZENLENS (Device) $1,025
  • CE-marked KXLA system (Device) $825.00
  • EYSUVIS (Drug) $700.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Optometrist Doctors in San Diego